DalsnaFinance › IPOs › Aprea Therapeutics › IPO
Aprea Therapeutics, Inc. completed its initial public offering on NASDAQ on October 3, 2019, pricing at $15.00 a share.
| Ticker | APRE |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | October 3, 2019 |
| Offering price | $15.00 |
| Shares offered | 5,666,667 |
| Total raised | $85M |
Aprea Therapeutics, Inc. sold 5,666,667 shares at $15.00 each on NASDAQ. Multiplied out, that is $85 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $85 million total recorded for the deal.
Aprea Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Aprea Therapeutics, Inc.. This page is general information, not investment advice.